Leptin and Liver Enzymes Responses to Aerobic Training in Hepatitis c Patients

Study Overview
=================
Brief Summary
-----------------
Exercise is one of the most vital components of health maintenance. Exercising regularly maintains the cardiovascular system health, promotes the health of liver, and declines the risks of complications induced by CHCV. Since overweight is the main risk factor for IR and type 2 DM which may speed the liver disease progression among HCV patients, exercise is very important for maintenance and loss of weight. Further, exercise can relieve the side effects of medications of HCV, improve immunity, promote a sense of well-being, reduce levels of chronic fatigue, improve blood oxygen levels and increase the endorphins excretion which makes the patients fully energized (Elgendi, Shebl A, Sliem M, and Gary FA, 2018). Studies on exercise effect in patients with CHCV are quite scarce (de Sousa Fernandes et al., 2019). Decreased leptin levels by exercise positively modulate insulin signaling and inhibit pathology progression (Anaruma et al., 2019). Since studies investigated physical activity effect on regulating HCV related leptin levels are very little, the present study aimed to explore the response of serum leptin and liver enzymes to aerobic exercise in nondiabetic overweight men with CHCV.

Detailed Description
-----------------
The study group (n=20) received three sessions of aerobic walking exercise per week for 3 months. Every session was done on an electronic treadmill with no inclination started with 5 minutes warm-up then 30 minutes of moderate-intensity aerobic training with 60-75% of target heart rate then followed or ended by 5 minutes cool down. The control group (n=20) will receive no training.

Official Title
-----------------
The Effect of Aerobic Exercise on Liver Enzymes in Overweight Prediabetic Patients With Hepatitis c

Conditions
-----------------
Hepatitis C

Intervention / Treatment
-----------------
* Behavioral: aerobic treadmill exercise


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Men with hepatitis C patients at least from 6 months BMI ranged ≥ 25 to < 30 kg/m2. fasting blood glucose level (FBG) < 100 mg/dl. waist circumference < 102 cm. Exclusion Criteria: Besides the excluded individuals who participated in any form of physical training in the last 6 months, excluded patients by a physician will be patients with acute or other hepatitis types, cirrhotic or hepatocellular carcinoma, renal or respiratory problems, cardiovascular and neurologic diseases, and hypertension

Ages Eligible for Study
-----------------
Minimum Age: 40 Years
Maximum Age: 70 Years

Sexes Eligible for Study
-----------------
Male

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Triple


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: study group<br>The study group (n=20) will receive three sessions of aerobic walking exercise per week for 3 months in addition to the traditional medical treatment | Behavioral: aerobic treadmill exercise<br>* The study group (n=20) received three sessions of aerobic exercise per week for 3 months. Every session was done on an electronic treadmill with no inclination started with 5 minutes warm-up then 30 minutes of moderate-intensity aerobic training with 60-75% of target heart rate then followed or ended by 5 minutes cool down.<br>|
| No Intervention: control group<br>The control group (n=20) will receive no training | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Leptin | It will be measured in plasma | It will be after 12-week training | 
| Liver enzymes | Serum alanine and aspartate transaminases (AST), (ALT) will be measured in plasma | liver enzymes will be after 12-week training | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| weight | With an empty bladder and stomach, weight will be measured for every participant | It will be after 12-week training | 
| Waist circumference (WC) | WC will be measured with an inelastic tape at the umbilicus level | It will be after 12-week training | 
| fasting blood glucose (FBG) | FBG will be measured by On Call ® Plus Acon, REF G113- 214, made in China | It will be after 12-week training |